After the sensitization with human myeloma, IgE, IgE+ LAD2 were detected in high proportions (median 93.7%, range 86.0–95.2), whereas no IgEs were detected on NS LAD2 cells (median 0.7%; range 0.0–0.94). The gene discussed is IGHE; the disease is plasma cell myeloma.